In our study, we found that decompensated cirrhotic infected with SARS-CoV-2 had decreased lymphocytes and RBC count, lower hemoglobin, and ALB level, prolonged PT, and APTT as well as evaluated ALT, AST, and TBIL compared with COVID-19 patients without liver disease. This evidence concerns the gene GPT and liver disorder.